Retinset is a pharmaceutical company that develops a novel class of medicines to treat ophthalmic pathologies. Our mission is to advance our portfolio to clinical trials and improve the lives of those affected by neurovascular ophthalmic pathologies.
| Website | http://www.retinset.com |
| Employees | 5 (2 on RocketReach) |
| Technologies |
JavaScript
,
HTML
,
Twitter
+4 more
(view full list)
|
| Industry | Research Services |
| Keywords | Ophthalmic, Pharmaceutical, Ophthalmology, Drugs, Eye Care, Vision Care, Clinical Trials, Therapeutics, Medicine Development, New Drugs, Novel Therapies, Neurovascular, Development, Drug Discovery, Research, Biopharma |
| Competitors | Novartis, AbbVie, Sanofi, AstraZeneca, Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Genzyme Europe B.V., Sarepta Therapeutics, Inc. +43 more (view full list) |
Looking for a particular Retinset employee's phone or email?
Marta Guerrero is the CEO of Retinset.
2 people are employed at Retinset.